• OPEN AN ACCOUNT
Indian Indices
Sensex
72,781.89 -251.89
( -0.34%)
Global Indices
Nasdaq
51,707.15 -164.40
(-0.32%)
Dow Jones
7,828.98 0.74
(0.01%)
Hang Seng
67,780.30 2.78
(0.00%)
Nikkei 225
10,649.29 -6.99
(-0.07%)
Forex
USD-INR
95.69 -0.76
(-0.79%)
EUR-INR
107.00 -1.04
(-0.96%)
GBP-INR
126.57 -1.05
(-0.82%)
JPY-INR
0.60 -0.01
(-0.89%)

EQUITY - MARKET SCREENER

Nephro Care India Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
92991
INE0SUN01013
34.4850907
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NEPHROCARE
25.37
142.61
EPS(TTM)
Face Value()
Div & Yield %
3.41
10
0
 

Daulat Securities reports standalone net loss of Rs 2.95 crore in the March 2026 quarter
Jun 01,2026
Net Loss of Daulat Securities reported to Rs 2.95 crore in the quarter ended March 2026 as against net loss of Rs 1.94 crore during the previous quarter ended March 2025. Sales reported to Rs -2.84 crore in the quarter ended March 2026 as against Rs -1.72 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 1.79 crore in the year ended March 2026 as against net profit of Rs 1.62 crore during the previous year ended March 2025. Sales reported to Rs -1.21 crore in the year ended March 2026 as against Rs 2.39 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales-2.84-1.72 -65 -1.212.39 PL
OPM %110.56118.02 -193.3948.12 -
PBDT-3.06-1.89 -62 -1.901.67 PL
PBT-3.13-1.96 -60 -1.971.60 PL
NP-2.95-1.94 -52 -1.791.62 PL